Medtronic is not a company we have talked about in the past. The company as an investment opportunity has been a bit conflicted in our view and the technicals have been at odds with the fundamentals. The company reported earnings on Jan 25, and while it is profitable, the company seems to be having some trouble growing EPS. The stock's price chart shows that progress is labored.
